Laurus Labs has granted stock options to eligible employees under its 2016, 2018, and 2021 schemes. A total of 4,23,125 options were granted at an exercise price of ₹754.50 per option, 25% less than the market value on January 22, 2026. Vesting occurs in stages, starting July 1, 2027.
Stock Option Grants
Laurus Labs has approved the grant of stock options to its eligible employees. The grants were approved on January 23, 2026, covering multiple employee stock option schemes.
Details of the Grants
Three distinct grants were approved:
- Grant V (2016 Scheme): 55,500 options were granted to 36 eligible employees.
- Grant V (2018 Scheme): 1,74,625 options were granted to 1,119 eligible employees of the Company and its subsidiaries.
- Grant III (2021 Scheme): 1,93,000 options were granted to 39 eligible employees of the Company and its subsidiaries.
Each option has a face value of ₹2 and an exercise price of ₹754.50. This price is 25% less than the market value of the share on January 22, 2026.
Effective Date
The effective date for all the grants is July 01, 2025.
Vesting Schedule
The vesting of options will occur in stages:
- 25% vest on July 01, 2027 (two years from the grant date).
- 25% vest on July 01, 2028 (three years from the grant date).
- 50% vest on July 01, 2029 (four years from the grant date).
Additional Vesting Stage
- An additional 25% vest on July 01, 2030 (five years from the grant date).
Vested options must be exercised within one year of their vesting date, or they will lapse.
Source: BSE
